Our clients include world's top universities and pharmaceutical organizations
bluebird bio
Saturday, December 2, 2023
bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
Arcutis Biotherapeutics
Wednesday, November 29, 2023
FDA Accepts Arcutis’ Supplemental New Drug Application for Roflumilast Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to Age 6
Adaptimmune Therapeutics
Wednesday, November 29, 2023
Adaptimmune Receives Transfer of IND for Lete-cel Program
REGENXBIO
Wednesday, November 29, 2023
REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial
XXVII World Congress and Vulvovaginal Disease Update 2024
Friday, September 13, 2024
Ljubljana, Slovenia
New England Journal of Medicine
Wednesday, November 29, 2023
Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors
New England Journal of Medicine
Wednesday, November 29, 2023
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia
New England Journal of Medicine
Wednesday, November 29, 2023
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
New England Journal of Medicine
Wednesday, November 29, 2023
Amivantamab plus Chemotherapy in NSCLC with
Gossamer Bio
Wednesday, November 29, 2023
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
Karuna Therapeutics
Wednesday, November 29, 2023
Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Amylyx Pharmaceuticals
Wednesday, November 29, 2023
Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PureTech Health
Wednesday, November 29, 2023
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Nature
Tuesday, November 28, 2023
A stable atmospheric-pressure plasma for extreme-temperature synthesis
Nature
Tuesday, November 28, 2023
Cellular development and evolution of the mammalian cerebellum
Nature
Tuesday, November 28, 2023
MSL2 ensures biallelic gene expression in mammals
Nature
Tuesday, November 28, 2023
An autonomous laboratory for the accelerated synthesis of novel materials
1222 1222
Ocugen
Wednesday, November 29, 2023
Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
Nuvalent
Wednesday, November 29, 2023
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results
SpringWorks Therapeutics
Wednesday, November 29, 2023
SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
Precigen
Wednesday, November 29, 2023
Precigen to Participate in the JMP Securities Hematology and Oncology Summit
Nature
Tuesday, November 28, 2023
Identification of constrained sequence elements across 239 primate genomes
Nature
Tuesday, November 28, 2023
On-surface synthesis of aromatic cyclo[10]carbon and cyclo[14]carbon
Nature
Tuesday, November 28, 2023
Landscape dynamics and the Phanerozoic diversification of the biosphere
Nature
Tuesday, November 28, 2023
A resonant sextuplet of sub-Neptunes transiting the bright star HD 110067
Xenon Pharmaceuticals
Wednesday, November 29, 2023
Xenon Pharmaceuticals Announces Proposed Public Offering
Avidity Biosciences
Tuesday, November 28, 2023
Avidity Biosciences to Participate in Upcoming Investor Conference
Arcturus Therapeutics
Tuesday, November 28, 2023
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics’ ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in Adults
Nature
Tuesday, November 28, 2023
Exploring large-scale entanglement in quantum simulation
Nature
Tuesday, November 28, 2023
Associative pyridinium electrolytes for air-tolerant redox flow batteries
Nature
Tuesday, November 28, 2023
Scaling deep learning for materials discovery
Nature
Tuesday, November 28, 2023
The genetic legacy of the expansion of Bantu-speaking peoples in Africa
391 391
Arctom is an e-commerce platform that provides 350K+ Building Blocks, Inhibitors, Agonists, Natural Products, PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, research, and industrial customers. We accelerate your research by providing better purchasing experience & services.